Quote  |  Bullboard  |  News  |  Opinion  |  Level II  |  Charts  |  Profile  |  Financials  |  Options  |  Price History

Neptune Technologies & Bioressources Inc T.NTB

Sector: Healthcare | Sub-Sector: Biotechnology

Neptune Technologies & Bioressources Inc. is a biotechnology company engaged in the development, manufacture and commercialization of marine-derived omega-3 polyunsaturated fatty acids.
Price: $2.65 | Change: $-0.02 | % Change: -0.75%
Volume: 6,850 | Day High/Low: 2.74/2.64 | 52 Week High/Low: 4.35/2.41
top

Snapshot

Last Traded: April 17, 2014 09:25 Transaction Volume: 6,850
Open: $2.65 Previous Close: $2.67
Bid: $2.56 Ask: $2.70
Bid Size: 13,000 Ask Size: 5,200
Market Cap: $195.1m Shares Out: 73.6m
PE Ratio: N/A Dividend Yield: N/A
Scale: 1d 5d 3m 6m 1y 2y 5y
Type: Line Area OHLC

Advanced Charts

Latest News

Neptune Technologies & Bioressources (T.NTB) shareholders push for change

Neptune Technologies & Bioressources (T.NTB) shareholder collective examines management changes in order to enhance share value

Stockhouse Editorial   7 days ago
0 stars

Shareholders of Neptune Technologies & Bioressources Inc. evaluate potential means to enhance shareholder value

Canada NewsWire   8 days ago
0 stars

Neptune Announces Closing of CAD$2.5 Million Private Placement

GlobeNewswire   April 4, 2014
0 stars

Neptune Technologies & Bioressources (T.NTB) dips 4% on patent litigation update

Neptune Technologies & Bioressources (T.NTB) provides patent litigation update with Enzymotec USA and shares slip 4%

Gaalen Engen   April 1, 2014
0 stars

Neptune & Acasti Give Update on Patent Litigations With Enzymotec

GlobeNewswire   April 1, 2014
0 stars

Latest Bullboard Posts